A new long-term weight-loss medication called Beliviq, which had been approved by FDA, will be available to patients by next week.
The drug, which received FDA approval almost a year ago, makes users feel that they are full by working on serotonin transmitters in the brain, which causes this reaction.
CBS News medical contributor Dr. Holly Phillips said on 'CBS This Morning: Saturday' that when a person feels full, they eat less, and then they see the weight loss.
She said that Beliviq was considered to be effective, and people taking it lost around 3.7 percent of their body weight over the year, asserting that in studies the drug worked better in non-diabetics than people who already were diagnosed with that disease.
She said that the drug is not a miracle cure for obesity, but people have to look at it from a health perspective, where if an obese person loses 5 percent of their body weight it can truly benefit you.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
